Wyrick Robbins attorney Ken Eheman, will be participating in a panel at the upcoming BIO International Convention being held May 3-6, 2010 at McCormick Place in Chicago, Illinois.
Hosted by the Biotechnology Industry Organization, the BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech. It offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.
Ken will speak in a breakout session entitled “Bridges Over Troubled Water and M&A ‘á la carte’: Financing and Exiting" during the finance track on Wednesday, May 5th.
This panel will focus on the approaches being used by investors, management teams and boards to fund companies in a tough market, including the creative use of bridge financing structures, aggressive project prioritization and the adoption of corporate structures that allow for a “menu-driven” approach to M&A and exits. Panelists will also discuss pre-emptive reorganization of individual programs into separate legal entities to facilitate M&A and the implications of these trends for structuring and launching new biotech ventures.
“While the economy and capital markets show signs of improvement, IPOs will only be available to a select few issuers,” said Ken. “This topic will be particularly relevant to any life science company with a potential exit on the horizon.”
Ken practices in the area of corporate and securities law at Wyrick Robbins, including company formation, venture capital financings, private placements, public offerings, mergers and acquisitions, and strategic partnerships. Ken’s practice focuses on the life sciences industry and he has experience representing start-up and emerging growth companies, public companies, underwriters and venture capitalists.